Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2222431rdf:typepubmed:Citationlld:pubmed
pubmed-article:2222431lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2222431lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:2222431lifeskim:mentionsumls-concept:C1383501lld:lifeskim
pubmed-article:2222431lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:2222431lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:2222431lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:2222431lifeskim:mentionsumls-concept:C0075857lld:lifeskim
pubmed-article:2222431pubmed:issue3lld:pubmed
pubmed-article:2222431pubmed:dateCreated1990-11-16lld:pubmed
pubmed-article:2222431pubmed:abstractTextThe effect of the cytoprotective bile acid tauroursodeoxycholic acid (TUDCA) on basal cytosolic free Ca++ (Ca++)i and receptor-mediated (Ca++)i increase was studied in human polymorphonuclear neutrophils using the fluorescent dye quin2. Basal levels of (Ca++)i were 96 +/- 6 nmol/l (mean +/- SEM, n = 48). TUDCA and its cytotoxic epimer taurochenodeoxycholic acid (TCDCA) at 500 mumols/l increased (Ca++)i by 31 +/- 12 and 27 +/- 7 nmol/l, respectively (n = 6, p less than 0.05). Stimulation of neutrophils with the chemotactic tripeptide N-formyl-methionyl-leucyl-phenylalanine (FMLP; 10(-7) mol/l) induced a (Ca++)i increase of 200 +/- 32 nmol/l which was inhibited after preincubation with TUDCA (500 mumols/l) or TUDCA + TCDCA (500 mumols/l, each) by 60.1% and 59.5%, respectively, but not with TCDCA (500 mumols/l) alone. The inhibitory effect of TUDCA on FMLP-induced (Ca++)i increase was strongly concentration-dependent and was nearly complete at 1000 mumols/l. Since (Ca++)i is discussed as a mediator of cellular injury we hypothesize that TUDCA may exert its protective effects at least partly via inhibition of (Ca++)i-mediated cytotoxic processes.lld:pubmed
pubmed-article:2222431pubmed:languageenglld:pubmed
pubmed-article:2222431pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2222431pubmed:citationSubsetIMlld:pubmed
pubmed-article:2222431pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2222431pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2222431pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2222431pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2222431pubmed:statusMEDLINElld:pubmed
pubmed-article:2222431pubmed:monthSeplld:pubmed
pubmed-article:2222431pubmed:issn0006-291Xlld:pubmed
pubmed-article:2222431pubmed:authorpubmed-author:PaumgartnerGGlld:pubmed
pubmed-article:2222431pubmed:authorpubmed-author:ThielMMlld:pubmed
pubmed-article:2222431pubmed:authorpubmed-author:BeuersUUlld:pubmed
pubmed-article:2222431pubmed:authorpubmed-author:BardenheuerHHlld:pubmed
pubmed-article:2222431pubmed:issnTypePrintlld:pubmed
pubmed-article:2222431pubmed:day28lld:pubmed
pubmed-article:2222431pubmed:volume171lld:pubmed
pubmed-article:2222431pubmed:ownerNLMlld:pubmed
pubmed-article:2222431pubmed:authorsCompleteYlld:pubmed
pubmed-article:2222431pubmed:pagination1115-21lld:pubmed
pubmed-article:2222431pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2222431pubmed:meshHeadingpubmed-meshheading:2222431-...lld:pubmed
pubmed-article:2222431pubmed:meshHeadingpubmed-meshheading:2222431-...lld:pubmed
pubmed-article:2222431pubmed:meshHeadingpubmed-meshheading:2222431-...lld:pubmed
pubmed-article:2222431pubmed:meshHeadingpubmed-meshheading:2222431-...lld:pubmed
pubmed-article:2222431pubmed:meshHeadingpubmed-meshheading:2222431-...lld:pubmed
pubmed-article:2222431pubmed:meshHeadingpubmed-meshheading:2222431-...lld:pubmed
pubmed-article:2222431pubmed:meshHeadingpubmed-meshheading:2222431-...lld:pubmed
pubmed-article:2222431pubmed:meshHeadingpubmed-meshheading:2222431-...lld:pubmed
pubmed-article:2222431pubmed:year1990lld:pubmed
pubmed-article:2222431pubmed:articleTitleTauroursodeoxycholic acid inhibits the cytosolic Ca++ increase in human neutrophils stimulated by formyl-methionyl-leucyl-phenylalanine.lld:pubmed
pubmed-article:2222431pubmed:affiliationDepartment of Medicine II, University of Munich, F.R.G.lld:pubmed
pubmed-article:2222431pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2222431pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2222431pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2222431lld:pubmed